To sum up, high expressions of GSTA2, NAT8, SLC17A3, and SLC17A4 forebode a favorable prognosis, while the lower expression of all DEGs except FABP7 might predict a higher risk of ccRCC. This evidence concerns the gene SLC17A4 and nonpapillary renal cell carcinoma.